Observational studyTransplantation and cellular therapy2021

Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic Malignancies.

Xin Shelley Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.